The OR appears to have modified the ‘Large’ effect size (borderline significance) to a smaller (non-significant) effect size.
← all excerpts
Interpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30.
1
—
—